APstem Therapeutics logo

APstem Therapeutics

An unprecedented era of stem cell therapy has arrived!

7 employees · est. 2017 · Fremont, United States

VS
Rebirthel Co.,Ltd. logo

Rebirthel Co.,Ltd.

An independent biocompany, developing cellular immunotherapies for cancer, based on Kyoto.

3 employees · est. 2019 · Kyoto, Japan

APstem Therapeutics is the older company (2017 vs 2019).

Side-by-Side Comparison

APstem Therapeutics Rebirthel Co.,Ltd.
Founded
2017 older 2019
Headquarters
Fremont, United States Kyoto, Japan
Employees
7 3
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Health Care, Health and Wellness
Funding Stage
Seed Series Unknown
Total Funding
$4.30M Not tracked yet
Funding Rounds
3 1
Services
Development of regenerative cell therapies, Research and innovation in stem cell technology, Manufacturing of off-the-shelf stem cell products Not tracked yet
Target Customers
Healthcare providers treating chronic diseases, Patients with Type 1 Diabetes, Patients with autoimmune and degenerative diseases, Biomedical research institutions Not tracked yet
Taxonomy
Stem Cell Therapy, Medical Breakthrough, Regenerative Medicine, Aging Research, Healthcare Innovation, Disease Treatment, APSCs™, Adult Pluripotent Stem Cells, Biomedical Technology, Cellular Therapy Biopharmaceuticals, Cellular Immunotherapy, Cancer Treatment, Pluripotent Stem Cells, Cell-based Therapy, Immunotherapy, Regenerative Medicine, Cancer Research, T Cell Therapy, Kyoto University, Innovation, Oncology, Biomedicine
Website
apstemtx.com rebirthel.com
APstem Therapeutics logo

About APstem Therapeutics

APstem Therapeutics is pioneering an innovative approach in the biotechnology and healthcare sectors with its breakthrough discovery of Adult Pluripotent Stem Cells (APSCs™). Founded in 2017 and based in the United States, the company aims to tackle difficult-to-heal diseases and address aging-relat...

Rebirthel Co.,Ltd. logo

About Rebirthel Co.,Ltd.

Rebirthel Co.,Ltd. is an independent biocompany based in Kyoto, Japan that is focused on the development of cellular immunotherapies for cancer. The company, founded in 2019, aims to realize cell-based therapies against cancer and other immune-related diseases by utilizing universal T cells regenera...

We will tell you when either one moves

BounceWatch watches APstem Therapeutics and Rebirthel Co.,Ltd. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at APstem Therapeutics and Rebirthel Co.,Ltd. — by email.

Frequently Asked Questions

APstem Therapeutics — An unprecedented era of stem cell therapy has arrived!. Rebirthel Co.,Ltd. — An independent biocompany, developing cellular immunotherapies for cancer, based on Kyoto.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
APstem Therapeutics has raised $4.30M while Rebirthel Co.,Ltd. has raised undisclosed funding.
APstem Therapeutics and Rebirthel Co.,Ltd. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare APstem Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at APstem Therapeutics on 12 Sep 2024, and Rebirthel Co.,Ltd. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes